Digital Health Technology England Approves Joenja for Ultra-Rare Disease While EU Review ContinuesMarch 13, 2025 Pharming’s Joenja, a treatment for APDS, has been approved for reimbursement in England after NICE reversed its earlier rejection. The EU regulatory review is still ongoing.
